TABLE 1.

Overview of drugs and investigational compounds used with IMD platform for multiplex in situ drug response screen.

Minocycline	Donepezil	Riluzole	SAHA	ABAH	Paclitaxel
Tetracycline antibiotic	inhibitor of acetylcholinesterase (AChE)	Glutamate inhibitor.NMDA receptor inhibitor	HDAC inhibitor	Myeloperoxidase inhibitor	Microtubule polymer stabilizer
P7C3	Sulfasalazine	Etomoxir	Buthionine Sulfoximine (BSO)	AGI-25696	SnMP(Tin mesoporhyrin)
Neuroprotective chemical that targets NAMPT	Inhibitor of NF-kB,TGF-β and COX-2	Inhibitor of carnitine palmitoyltransferase-1	Depletes cellular glutathione levels	Methionine adenosyltransferase 2A(MATA2) inhibitor	Inhibitor of heme oxidation